EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM)
[ad_1] EVP Strategy and Corporate Development Matthew Dolan has sold 1,990 shares of DexCom Inc (NASDAQ:DXCM) on April 15, 2024, according to a recent SEC filing.DexCom Inc, a medical device company, specializes in the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. These systems are designed to help patients …
EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM) Read More »